$BIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-RAD LABORATORIES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-RAD LABORATORIES, INC.. Get notifications about new insider transactions in BIO-RAD LABORATORIES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2021 | BIO | BIO-RAD LABORATORI ... | RAMALINGAM AJIT | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 276 | 0 | 1,108 | |
May 03 2021 | BIO | BIO-RAD LABORATORI ... | RAMALINGAM AJIT | SVP, Chief Accounti ... | Payment of Exercise | F | 640.73 | 96 | 61,510 | 222 | 318 to 222 (-30.19 %) |
May 03 2021 | BIO | BIO-RAD LABORATORI ... | RAMALINGAM AJIT | SVP, Chief Accounti ... | Buy | M | 0.00 | 276 | 0 | 318 | 42 to 318 (+657.14 %) |
Apr 30 2021 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Apr 30 2021 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 640.73 | 466 | 298,580 | 1,268 | 1.7 K to 1.3 K (-26.87 %) |
Apr 30 2021 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,000 | 0 | 1,734 | 734 to 1.7 K (+136.24 %) |
Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 700 | 0 | 2,100 | |
Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Payment of Exercise | F | 592.23 | 250 | 148,058 | 907 | 1.2 K to 907 (-21.61 %) |
Apr 09 2021 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Buy | M | 0.00 | 700 | 0 | 1,157 | 457 to 1.2 K (+153.17 %) |
Dec 17 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ STEVEN D | 10% Owner | Gift | G | 0.00 | 27 | 0 | 12,838 | 12.8 K to 12.8 K (+0.21 %) |
Dec 17 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ STEVEN D | 10% Owner | Gift | G | 0.00 | 27 | 0 | 25,066 | 25 K to 25.1 K (+0.11 %) |
Dec 17 2020 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Option Exercise | M | 0.00 | 502 | 0 | 2,009 | |
Dec 17 2020 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Payment of Exercise | F | 576.72 | 174 | 100,349 | 328 | 502 to 328 (-34.66 %) |
Dec 17 2020 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Buy | M | 0.00 | 502 | 0 | 502 | 0 to 502 |
Dec 17 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Sell | S | 580.67 | 374 | 217,171 | 3,669 | 4 K to 3.7 K (-9.25 %) |
Dec 16 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Gift | G | 0.00 | 27 | 0 | 12,838 | 12.8 K to 12.8 K (+0.21 %) |
Dec 16 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Gift | G | 0.00 | 27 | 0 | 298,274 | 298.2 K to 298.3 K (+0.01 %) |
Dec 14 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ ALICE N | Director | Gift | G | 0.00 | 162 | 0 | 438,518 | 438.7 K to 438.5 K (-0.04 %) |
Dec 14 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ ALICE N | Director | Gift | G | 0.00 | 1,800 | 0 | 1,791,821 | 1.8 M to 1.8 M (-0.10 %) |
Nov 10 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 159.32 | 1,200 | 191,184 | 600 | |
Nov 10 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Gift | G | 0.00 | 423 | 0 | 3,699 | 4.1 K to 3.7 K (-10.26 %) |
Nov 10 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 641.53 | 246 | 157,816 | 4,122 | 4.4 K to 4.1 K (-5.63 %) |
Nov 10 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 640.78 | 734 | 470,333 | 4,368 | 5.1 K to 4.4 K (-14.39 %) |
Nov 10 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 639.62 | 220 | 140,716 | 5,102 | 5.3 K to 5.1 K (-4.13 %) |
Nov 10 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 159.32 | 1,200 | 191,184 | 5,322 | 4.1 K to 5.3 K (+29.11 %) |
Sep 15 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,200 | 0 | 0 | |
Sep 15 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 505.02 | 1,587 | 801,467 | 298,247 | 299.8 K to 298.2 K (-0.53 %) |
Sep 15 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 3,200 | 0 | 299,834 | 296.6 K to 299.8 K (+1.08 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 0 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 505.02 | 52 | 26,261 | 4,688 | 4.7 K to 4.7 K (-1.10 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 150 | 0 | 4,740 | 4.6 K to 4.7 K (+3.27 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 505.02 | 298 | 150,496 | 4,122 | 4.4 K to 4.1 K (-6.74 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 4,420 | 3.8 K to 4.4 K (+15.71 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 505.02 | 298 | 150,496 | 4,043 | 4.3 K to 4 K (-6.86 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 4,341 | 3.7 K to 4.3 K (+16.04 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 0 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 139.56 | 500 | 69,780 | 0 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 333.34 | 371 | 123,669 | 1,485 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 326.15 | 500 | 163,075 | 1,500 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 215.98 | 500 | 107,990 | 1,000 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 160.37 | 400 | 64,148 | 400 | |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 505.02 | 248 | 125,245 | 22,495 | 22.7 K to 22.5 K (-1.09 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 22,743 | 22.2 K to 22.7 K (+2.25 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 505.02 | 318 | 160,596 | 22,243 | 22.6 K to 22.2 K (-1.41 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 139.56 | 500 | 69,780 | 22,561 | 22.1 K to 22.6 K (+2.27 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 503.45 | 308 | 155,063 | 22,061 | 22.4 K to 22.1 K (-1.38 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 333.34 | 371 | 123,669 | 22,369 | 22 K to 22.4 K (+1.69 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 503.45 | 412 | 207,421 | 21,998 | 22.4 K to 22 K (-1.84 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 326.15 | 500 | 163,075 | 22,410 | 21.9 K to 22.4 K (+2.28 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 503.45 | 357 | 179,732 | 21,910 | 22.3 K to 21.9 K (-1.60 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 215.98 | 500 | 107,990 | 22,267 | 21.8 K to 22.3 K (+2.30 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 503.45 | 263 | 132,407 | 21,767 | 22 K to 21.8 K (-1.19 %) |
Sep 14 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 160.37 | 400 | 64,148 | 22,030 | 21.6 K to 22 K (+1.85 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,000 | 0 | 3,000 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,000 | 0 | 3,000 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 5,200 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 5,200 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 7,800 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 7,800 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 480.20 | 1,488 | 714,538 | 296,634 | 298.1 K to 296.6 K (-0.50 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 480.20 | 1,488 | 714,538 | 296,634 | 298.1 K to 296.6 K (-0.50 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 3,000 | 0 | 298,122 | 295.1 K to 298.1 K (+1.02 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 3,000 | 0 | 298,122 | 295.1 K to 298.1 K (+1.02 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 484.23 | 1,290 | 624,657 | 418,971 | 420.3 K to 419 K (-0.31 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 484.23 | 1,290 | 624,657 | 418,971 | 420.3 K to 419 K (-0.31 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 420,261 | 417.7 K to 420.3 K (+0.62 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 420,261 | 417.7 K to 420.3 K (+0.62 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 484.23 | 1,290 | 624,657 | 417,661 | 419 K to 417.7 K (-0.31 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 484.23 | 1,290 | 624,657 | 417,661 | 419 K to 417.7 K (-0.31 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 418,951 | 416.4 K to 419 K (+0.62 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 418,951 | 416.4 K to 419 K (+0.62 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 1,000 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 500 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 484.23 | 237 | 114,763 | 1,723 | 2 K to 1.7 K (-12.09 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 1,960 | 1.5 K to 2 K (+34.25 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 484.23 | 173 | 83,772 | 1,460 | 1.6 K to 1.5 K (-10.59 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 1,633 | 1.1 K to 1.6 K (+44.13 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 484.23 | 173 | 83,772 | 1,133 | 1.3 K to 1.1 K (-13.25 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 1,306 | 806 to 1.3 K (+62.03 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 170 | 0 | 170 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 180 | 0 | 360 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 180 | 0 | 540 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 484.23 | 59 | 28,570 | 4,590 | 4.6 K to 4.6 K (-1.27 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 170 | 0 | 4,649 | 4.5 K to 4.6 K (+3.80 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 484.23 | 63 | 30,506 | 4,479 | 4.5 K to 4.5 K (-1.39 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 180 | 0 | 4,542 | 4.4 K to 4.5 K (+4.13 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 484.23 | 63 | 30,506 | 4,362 | 4.4 K to 4.4 K (-1.42 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 180 | 0 | 4,425 | 4.2 K to 4.4 K (+4.24 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 600 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 484.23 | 298 | 144,301 | 3,741 | 4 K to 3.7 K (-7.38 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 4,039 | 3.4 K to 4 K (+17.45 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 484.23 | 226 | 109,436 | 3,439 | 3.7 K to 3.4 K (-6.17 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 3,665 | 3.1 K to 3.7 K (+19.58 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 484.23 | 208 | 100,720 | 3,065 | 3.3 K to 3.1 K (-6.36 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 3,273 | 2.7 K to 3.3 K (+22.45 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 400 | 0 | 400 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 478.82 | 199 | 95,285 | 21,630 | 21.8 K to 21.6 K (-0.91 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 400 | 0 | 21,829 | 21.4 K to 21.8 K (+1.87 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 1,000 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 484.23 | 248 | 120,089 | 21,429 | 21.7 K to 21.4 K (-1.14 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 21,677 | 21.2 K to 21.7 K (+2.36 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 484.23 | 248 | 120,089 | 21,177 | 21.4 K to 21.2 K (-1.16 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 21,425 | 20.9 K to 21.4 K (+2.39 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 600 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 484.23 | 298 | 144,301 | 3,820 | 4.1 K to 3.8 K (-7.24 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 4,118 | 3.5 K to 4.1 K (+17.06 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 484.23 | 247 | 119,605 | 3,518 | 3.8 K to 3.5 K (-6.56 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 3,765 | 3.2 K to 3.8 K (+18.96 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 484.23 | 208 | 100,720 | 3,165 | 3.4 K to 3.2 K (-6.17 %) |
Sep 09 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 3,373 | 2.8 K to 3.4 K (+21.64 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,319 | 0 | 9,278 | |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 494.24 | 1,150 | 568,376 | 416,351 | 417.5 K to 416.4 K (-0.28 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,319 | 0 | 417,501 | 415.2 K to 417.5 K (+0.56 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 464 | 0 | 1,856 | |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 494.24 | 161 | 79,573 | 806 | 967 to 806 (-16.65 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 464 | 0 | 967 | 503 to 967 (+92.25 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 556 | 0 | 2,228 | |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 494.24 | 193 | 95,388 | 2,773 | 3 K to 2.8 K (-6.51 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 556 | 0 | 2,966 | 2.4 K to 3 K (+23.07 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 371 | 0 | 1,485 | |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 494.24 | 184 | 90,940 | 20,925 | 21.1 K to 20.9 K (-0.87 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 371 | 0 | 21,109 | 20.7 K to 21.1 K (+1.79 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 154 | 0 | 620 | |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 494.24 | 54 | 26,689 | 4,245 | 4.3 K to 4.2 K (-1.26 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 154 | 0 | 4,299 | 4.1 K to 4.3 K (+3.72 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 556 | 0 | 2,228 | |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 494.24 | 193 | 95,388 | 2,673 | 2.9 K to 2.7 K (-6.73 %) |
Sep 08 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 556 | 0 | 2,866 | 2.3 K to 2.9 K (+24.07 %) |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | A | 524.30 | 1,444 | 757,089 | 1,444 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | A | 0.00 | 1,444 | 0 | 1,444 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | A | 0.00 | 482 | 0 | 482 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | A | 524.30 | 7,220 | 3,785,446 | 7,220 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | A | 0.00 | 7,220 | 0 | 7,220 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | A | 524.30 | 1,733 | 908,612 | 1,733 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | A | 0.00 | 1,733 | 0 | 1,733 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 524.30 | 2,166 | 1,135,634 | 2,166 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 2,166 | 0 | 2,166 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | A | 524.30 | 1,733 | 908,612 | 1,733 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | A | 0.00 | 1,733 | 0 | 1,733 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 524.30 | 3,610 | 1,892,723 | 3,610 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 3,610 | 0 | 3,610 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Option Exercise | A | 524.30 | 1,733 | 908,612 | 1,733 |